98 related articles for article (PubMed ID: 30561228)
1. Elevated serum CCL4/MIP-1β levels in postmenopausal osteoporosis patients are linked with disease severity.
Yang XW; Wang F; Qin RZ; Zhou QL; Huang HX
Biomark Med; 2019 Jan; 13(1):17-25. PubMed ID: 30561228
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Serum CCL3/MIP-1α Levels with Disease Severity in Postmenopausal Osteoporotic Females.
Wan H; Qian TY; Hu XJ; Huang CY; Yao WF
Balkan Med J; 2018 Jul; 35(4):320-325. PubMed ID: 29666038
[TBL] [Abstract][Full Text] [Related]
3. Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients.
Chen YD; Huang CY; Liu HY; Yao WF; Wu WG; Lu YL; Wang W
Br J Biomed Sci; 2016 Jul; 73(3):121-128. PubMed ID: 27476376
[TBL] [Abstract][Full Text] [Related]
4. Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients.
Yang XW; Wang XS; Cheng FB; Wang F; Wan L; Wang F; Huang HX
Clin Lab; 2016 Nov; 62(11):2173-2181. PubMed ID: 28164676
[TBL] [Abstract][Full Text] [Related]
5. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study.
Wang W; Wang ZP; Huang CY; Chen YD; Yao WF; Shi BM
Genet Test Mol Biomarkers; 2019 Jul; 23(7):480-486. PubMed ID: 31157986
[No Abstract] [Full Text] [Related]
6. Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis.
Wang W; Huang CY; Wang ZP; Xu SS; Qian TY; Chen YD; Wu WG
J Med Biochem; 2019 Jul; 38(3):353-360. PubMed ID: 31156346
[TBL] [Abstract][Full Text] [Related]
7. Plasma LncRNA MALAT1 Expressions Are Negatively Associated with Disease Severity of Postmenopausal Osteoporosis.
Qian TY; Wan H; Huang CY; Hu XJ; Yao WF
Lab Med; 2022 Sep; 53(5):446-452. PubMed ID: 35311990
[TBL] [Abstract][Full Text] [Related]
8. Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.
Chang IC; Chiang TI; Yeh KT; Lee H; Cheng YW
Osteoporos Int; 2010 Aug; 21(8):1401-9. PubMed ID: 20238102
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic value of PD-1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients.
Cai XP; Zhao Q; Guo ZD; Lin SJ; Chen ZX; Chen MY; Zheng L; Zhao KW
J Clin Lab Anal; 2020 Jun; 34(6):e23223. PubMed ID: 32065479
[TBL] [Abstract][Full Text] [Related]
10. Serum chitotriosidase in postmenopausal women with severe osteoporosis.
Musumeci M; Palermo A; D'Onofrio L; Vadalà G; Greto V; Di Stasio E; Maddaloni E; Di Rosa M; Tibullo D; Angeletti S; Napoli N; Denaro V; Manfrini S
Osteoporos Int; 2016 Feb; 27(2):711-6. PubMed ID: 26243359
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.
Akter M; Roknuzzaman ASM; Shahriar M; Islam SMA; Ahmed Bhuiyan M; Qusar MMAS; Kabir ER; Islam R
PLoS One; 2024; 19(6):e0305734. PubMed ID: 38889138
[TBL] [Abstract][Full Text] [Related]
12. Beta-2 microglobulins in postmenopausal osteoporosis.
Akinci A; Ozçakar L
Rheumatol Int; 2002 Aug; 22(4):173-4. PubMed ID: 12418487
[No Abstract] [Full Text] [Related]
13. Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
Cai X; Yi X; Zhang Y; Zhang D; Zhi L; Liu H
Osteoporos Int; 2018 Sep; 29(9):2041-2047. PubMed ID: 29855663
[TBL] [Abstract][Full Text] [Related]
14. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
15. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
16. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study.
Wu WT; Lee RP; Wang CH; Fang TC; Lin NT; Chen IH; Hsu BG
J Womens Health (Larchmt); 2010 Apr; 19(4):785-90. PubMed ID: 20210559
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty.
Glowacki J; Hurwitz S; Thornhill TS; Kelly M; LeBoff MS
J Bone Joint Surg Am; 2003 Dec; 85(12):2371-7. PubMed ID: 14668507
[TBL] [Abstract][Full Text] [Related]
18. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
[TBL] [Abstract][Full Text] [Related]
19. Role of APOE Gene in Bone Mineral Density and Incidence of Bone Fractures in Brazilian Postmenopausal Women.
Souza LS; Rochette NF; Pedrosa DF; Magnago RPL; Filho TBF; Vieira FLH; Fin IDCF; Eis SR; Graceli JB; Rangel LBA; Silva IV
J Clin Densitom; 2018; 21(2):227-235. PubMed ID: 28784276
[TBL] [Abstract][Full Text] [Related]
20. The role of serum TGF-beta isoforms as potential markers of osteoporosis.
Grainger DJ; Percival J; Chiano M; Spector TD
Osteoporos Int; 1999; 9(5):398-404. PubMed ID: 10550458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
